A literature survey on follow-up definitions on the use of infliximab in Crohn’s disease
Many clinical studies arbitrarily define follow-up durations as short-term, mid-term, or long-term, without standardized criteria. To examine existing research on the use of infliximab in Crohn’s disease to understand how these terms are defined and applied, a literature survey was conducted. Releva...
Saved in:
| Main Author: | Andy Wai Kan Yeung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/17562848251370099 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
by: Dario Sorrentino, et al.
Published: (2015-01-01) -
Infliximab in the Treatment of Crohn’s Disease
by: Brian Feagan
Published: (2000-01-01) -
Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease
by: Liji Chen, et al.
Published: (2025-08-01) -
Listeria Meningitis Complicating Infliximab Treatment for Crohn’s Disease
by: Geoffrey Williams, et al.
Published: (2005-01-01) -
Fulminant Legionellosis in Two Patients Treated with Infliximab for Crohn’s Disease: Case Series and Literature Review
by: Adam Hofmann, et al.
Published: (2009-01-01)